Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8586557
APP PUB NO 20110081331A1
SERIAL NO

12731374

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method for treating a hyperproliferative disorder characterized by expression of a mutant form of p53 in a subject, the method comprising administering to the subject a therapeutically effective amount of an agent which inhibits promyelocytic leukemia (PML) protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PETER MACCALLUM CANCER INSTITUTEEAST MELBOURNE VIC 3002

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Haupt, Susan Hawthorn East, AU 3 5
Haupt, Ygal Hawthorn East, AU 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 19, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00